A gene expression signature for Alzheimer's from finger prick blood spotted on a filter paper card. (20th December 2022)
- Record Type:
- Journal Article
- Title:
- A gene expression signature for Alzheimer's from finger prick blood spotted on a filter paper card. (20th December 2022)
- Main Title:
- A gene expression signature for Alzheimer's from finger prick blood spotted on a filter paper card
- Authors:
- Seligmann, Bruce
Babic, Milos
Scully, Kathleen
Yeakley, Joanne M
Sahagian, Gregory - Abstract:
- Abstract: Background: There is an unmet need for a minimally invasive clinical test using samples collected by medical staff or by self‐collection to screen persons at risk for Alzheimer's disease (AD) for initial diagnosis as well as for monitoring progression. Addressing this need is even more challenging for underserved and rural populations. Currently, use of whole blood has required venipuncture and RNA extraction. None‐the‐less, AD gene expression signatures using RNA extracted from whole blood have been reported by a number of groups. We have developed a direct, extraction‐free TempO‐Seq® assay of gene expression using blood from a finger prick spotted on filter paper. This novel method is perhaps the simplest and least invasive method of obtaining a blood sample and performing a test that can be used to identify a diagnostic Alzheimer's signature. Method: The targeted sequencing of the whole transcriptome via the TempO‐Seq® gene expression assay (Yeakley, PLosOne doi.org/10.1371/journal.pone.0178302 ) was adapted to utilize blood spotted on filter paper. Samples were obtained under an IRB‐approved protocol from normal volunteers and patients clinically diagnosed with AD or Parkinson's disease (PD). Result: A protocol that eliminated interference by components of whole blood with enzymes used in molecular biology assays was successfully implemented. This permitted a TempO‐Seq assay to be carried out without extraction of RNA from the filter paper blood spots. HighlyAbstract: Background: There is an unmet need for a minimally invasive clinical test using samples collected by medical staff or by self‐collection to screen persons at risk for Alzheimer's disease (AD) for initial diagnosis as well as for monitoring progression. Addressing this need is even more challenging for underserved and rural populations. Currently, use of whole blood has required venipuncture and RNA extraction. None‐the‐less, AD gene expression signatures using RNA extracted from whole blood have been reported by a number of groups. We have developed a direct, extraction‐free TempO‐Seq® assay of gene expression using blood from a finger prick spotted on filter paper. This novel method is perhaps the simplest and least invasive method of obtaining a blood sample and performing a test that can be used to identify a diagnostic Alzheimer's signature. Method: The targeted sequencing of the whole transcriptome via the TempO‐Seq® gene expression assay (Yeakley, PLosOne doi.org/10.1371/journal.pone.0178302 ) was adapted to utilize blood spotted on filter paper. Samples were obtained under an IRB‐approved protocol from normal volunteers and patients clinically diagnosed with AD or Parkinson's disease (PD). Result: A protocol that eliminated interference by components of whole blood with enzymes used in molecular biology assays was successfully implemented. This permitted a TempO‐Seq assay to be carried out without extraction of RNA from the filter paper blood spots. Highly expressed genes were attenuated to increase the sensitivity with which AD biomarker genes could be measured. The shelf‐life of blood spotted filter paper stored at room temperature was greater than 6 months. AD, PD, and normal control blood samples were assayed and a proposed gene expression signature for AD was identified. Conclusion: Use of a simple gene expression‐based assay of blood from a finger prick spotted on filter paper to diagnose AD is feasible. The spotted blood sample is stable for months at room temperature, permitting self‐collection or assisted collection and mailing of samples for testing. … (more)
- Is Part Of:
- Alzheimer's & dementia. Volume 18(2022)Supplement 5
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 18(2022)Supplement 5
- Issue Display:
- Volume 18, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 18
- Issue:
- 5
- Issue Sort Value:
- 2022-0018-0005-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-12-20
- Subjects:
- Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/alz.061996 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24783.xml